Harrow Health, Inc. is 10% Owner at Eton Pharmaceuticals, Inc. (ETON). They have made 1 open-market trade across 1 company since 2021, most recently 2021-04-12.
CIK 0001360214
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ETON | 1,982,000 | $99.6M |
Shares reported on the most recent Form 4, priced at the 2021-04-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ETON | SELL | 2021-04-12 | 2021-04-12 | $7.00 | $10.6M | +6.7% | +6.8% | -23.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.